DeepX Health
Curated by SignalDeveloper of AI-based diagnostic devices for the identification of malignant melanoma
Overview
Developer of AI-based diagnostic devices for the identification of malignant melanoma. It offers Dermosight device that helps in the screening and early detection of skin cancer. The device has AI-algorithms that records spectral radiance images and also uses physiological properties and morphology parameters to diagnose the health of the skin.
Key facts
- Founded
- 2019
- Headquarters
- Washington, DC, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view